BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 19182319)

  • 1. [Cystic fibrosis--review].
    Jonsdottir B; Bergsteinsson H; Baldursson O
    Laeknabladid; 2008 Dec; 94(12):831-7. PubMed ID: 19182319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastrointestinal complications of adult patients with cystic fibrosis].
    Bargon J; Stein J; Dietrich CF; Müller U; Caspary WF; Wagner TO
    Z Gastroenterol; 1999 Aug; 37(8):739-49. PubMed ID: 10494610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in cystic fibrosis therapies.
    Rowe SM; Clancy JP
    Curr Opin Pediatr; 2006 Dec; 18(6):604-13. PubMed ID: 17099358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respiratory disease in cystic fibrosis: from physiopathology to therapy. Kinesitherapy and pulmonary transplantation excluded].
    Reynaud-Gaubert M
    Rev Mal Respir; 1999 Sep; 16(4):495-509. PubMed ID: 10549060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel therapeutic possibilities in cystic fibrosis].
    Kilian K; Kisiel BM
    Pol Merkur Lekarski; 2006 May; 20(119):586-90. PubMed ID: 16875169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis: current concepts.
    Abrons HL
    W V Med J; 1993 Jun; 89(6):236-40. PubMed ID: 7686701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystic fibrosis].
    Høiby N; Koch C; Frederiksen B
    Nord Med; 1998 Dec; 113(10):328-30. PubMed ID: 9894407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes in patients with cystic fibrosis.
    Warwick G; Elston C
    Practitioner; 2011; 255(1742):29-32, 3. PubMed ID: 21932505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations.
    Kolesár P; Minárik G; Baldovic M; Ficek A; Kovács L; Kádasi L
    Gen Physiol Biophys; 2008 Dec; 27(4):299-305. PubMed ID: 19202204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
    Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
    J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing and managing cystic fibrosis in the developing world.
    Kabra SK; Kabra M; Shastri S; Lodha R
    Paediatr Respir Rev; 2006; 7 Suppl 1():S147-50. PubMed ID: 16798545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of cystic fibrosis.
    Wallace CS; Hall M; Kuhn RJ
    Clin Pharm; 1993 Sep; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapies for cystic fibrosis.
    Simakajornboon N; Davis SH
    J La State Med Soc; 1998 Dec; 150(12):629-37. PubMed ID: 9926704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
    Soferman R
    Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis in adults. From researcher to practitioner.
    Marelich GP; Cross CE
    West J Med; 1996 Apr; 164(4):321-34. PubMed ID: 8732732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis.
    Pongnimitprasert N; El-Benna J; Foglietti MJ; Gougerot-Pocidalo MA; Bernard M; Braut-Boucher F
    Ann Biol Clin (Paris); 2008; 66(6):621-9. PubMed ID: 19091660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.